May 9, 2014

Bayer agreed to acquire the consumer care business of U.S. pharmaceutical company Merck for a purchase price of $14.2 billion. The OTC acquisition will give Bayer the global No. 2 position in nonprescription products following recently announced consolidations in this growing healthcare industry segment, and will significantly enhance Bayer’s business across multiple therapeutic categories and geographies. Merck's consumer care business includes such leading brands as Claritin, Coppertone and Dr. Scholl’s. Pro forma sales of the combined businesses in 2013 amounted to $7.4 billion with Merck’s business contributing approximately $2.2 billion.

Upon completion of the acquisition, Bayer is expected to achieve global leadership positions in dermatology and gastrointestinals and advance to the No. 2 position in the cold, allergy, sinus and flu category. Bayer will remain No. 2 in nutritionals and No. 3 in analgesics. Overall, the proposed GlaxoSmithKline-Novartis combination represents the largest consumer health business with about 5.7% share, according to reports. The Bayer/Merck combination comes in second with around 4.5% share. McNeil Consumer rounds out the top three globally with a share just above 4%.

May 6, 2014

Bayer on Tuesday agreed to acquire the consumer care business of U.S. pharmaceutical company Merck for a purchase price of $14.2 billion.

May 6, 2014

In a related transaction to Tuesday morning's acquisition of Merck's OTC portfolio, Bayer also agreed to enter into a strategic pharma collaboration in the area of cardiovascular diseases with a focus on sGC modulation.

October 21, 2013

Bayer HealthCare last week moved into its new U.S. headquarters on a 94-acre campus in Whippany, N.J., consolidating Bayer HealthCare's operations that previously operated from Morristown, Montville and Wayne, N.J., and Tarrytown, N.Y., into one location.

June 10, 2013

A team of middle school students from Philip G. Vroom School in Bayonne took the top prize in Bayer’s first-ever Alka-Seltzer Rocket Contest at Liberty Science Center with a rocket that soared to 15.3 ft., Bayer HealthCare Consumer Care announced Monday.

May 1, 2013

Bayer HealthCare will buy birth-control product maker Conceptus for $1.1 billion, the companies said.

October 31, 2012

Bayer HealthCare on Tuesday signed a merger agreement to acquire Schiff Nutrition International, and with that, prominent supplement brands Digestive Advantage, MegaRed, Move Free and Airborne.

August 20, 2012

Bayer has been stepping up its game behind its Bayer Advanced Aspirin brand in an attempt to recreate its brand identity from a healthy heart supplement for people who’ve had a heart attack to what Bayer Aspirin had been in its heyday: the internal analgesic of choice.

June 13, 2012

Bayer on Tuesday announced that on July 1, Philip Blake will become senior Bayer representative USA, following a common company practice of assigning this oversight role to a senior executive already holding a significant business role or roles within the region.

June 4, 2012

An experimental drug made by Bayer HealthCare extended the length of time that patients with gastrointestinal tumors survived without their disease getting worse, according to results of a late-stage clinical trial released Monday.

April 20, 2012

Bayer on Friday announced that it is providing monetary support for disaster relief efforts through a $25,000 donation from the Bayer USA Foundation to the American Red Cross of southwestern Indiana.

April 20, 2012

Regulators have approved a new blood-glucose monitoring system made by Bayer HealthCare, the company said.

April 18, 2012

To encourage consumers to rethink aspirin for pain relief — according to a recent Bayer survey, only 8% of respondents reported taking aspirin more often that other OTC pain relievers — Bayer on Tuesday issued the Fast Relief Challenge and is giving away 100,000 bottles of Bayer Advanced Aspirin so consumers can put the pain reliever to the test.

January 19, 2012

Generic drug maker Watson Pharmaceuticals has launched its version of a contraceptive made by Bayer HealthCare Pharmaceuticals, Watson said.

December 19, 2011

Bayer recently engaged the Goldstein Group to rejuvenate the cough-cold Neo-Synephrine brand and improve the brand's identity on shelf.

November 28, 2011

Bayer Healthcare on Monday announced its "Countdown to Holiday Cheer" sweepstakes in support of its Aleve brand.

October 19, 2011

Emerson Group on Wednesday named Shane Brown to the group's Walmart team.

June 14, 2011

Bayer on Tuesday introduced its new Bayer Advanced Aspirin, billed as relieving pain “twice as fast” as the previous Extra Strength Bayer Aspirin.

May 23, 2011

Bayer has launched a reformulated aspirin called Bayer Advanced Aspirin that works in less than half the time of the company's regular aspirin, according to published reports.

May 10, 2011

The Food and Drug Administration will expedite its review of an investigational drug made by Bayer HealthCare Pharmaceuticals for treating tumors of the gastrointestinal tract, the company said Tuesday.

April 26, 2011

The Food and Drug Administration has approved a new storage option for a hemophilia A treatment made by Bayer HealthCare Pharmaceuticals, the drug maker said.

December 17, 2010

The Food and Drug Administration has approved a new oral contraceptive developed by Bayer.

July 12, 2010

Timothy Hayes, currently SVP and region head for Bayer HealthCare's consumer care division in North...

July 26, 2009

It’s simply not good enough to stock a company’s “better mousetrap” on a store shelf,...